FORE Biotherapeutics
FORE Biotherapeutics55
About
What does FORE Biotherapeutics do?
FORE Biotherapeutics is a precision oncology company dedicated to pioneering the development of novel cancer therapies. Their approach is deeply rooted in science and innovation, utilizing proprietary functional genomics to guide their therapeutic development. Their vision is to compassionately contribute to solving cancer. (formerly NovellusDX.)
What is FORE Biotherapeutics's revenue?
StartupHub estimates FORE Biotherapeutics's annual revenue at $10.5M (range $5.8M to $24.3M, 66% confidence), based on comparable companies in the sector.
What is FORE Biotherapeutics's valuation?
StartupHub estimates FORE Biotherapeutics's effective valuation at $76.1M (range $53.3M to $98.9M, 42% confidence), based on comparable companies in the sector.
How much funding has FORE Biotherapeutics raised?
FORE Biotherapeutics has raised a total of $232M in funding. The most recent round on record is Series D-2 Extension.
Where is FORE Biotherapeutics headquartered?
FORE Biotherapeutics is headquartered in Philadelphia, United States.
When was FORE Biotherapeutics founded?
FORE Biotherapeutics was founded in 2011.
What industry does FORE Biotherapeutics operate in?
FORE Biotherapeutics operates in Healthcare, Drug Development, Genomics, Next Generation Sequencing, Biotech, Oncology.
How many employees does FORE Biotherapeutics have?
FORE Biotherapeutics has approximately 56 people on record.
No comments yet. Be the first to share your take.